跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
令泽舒 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Linaclotide Capsules
Approved
化学药品
Linaclotide Capsules
AstraZeneca AG
🇨🇳 National Medical Products Administration
Approval Date
Mar 6, 2019
Approval ID
7MaoUM19VYn
Company
AstraZeneca AG
Type
化学药品
Approval Details
Approval Id
7MaoUM19VYn
Approval Number
H20191007
Generic Name
利那洛肽胶囊
Generic Name En
Linaclotide Capsules
Trade Name
令泽舒
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
290μg
Reg Date
2019-03-06
Expired Date
2024-01-08
Company Name
AstraZeneca AG
Company Address
Neuhofstrasse 34, 6340 Baar, Switzerland
Production Company Name
ALMAC PHARMA SERVICES LIMITED
Production Company Address
Seagoe Industrial Estate, Portadown, Craigavon, County Armagh, BT63 5UA, United Kingdom
Company Detail Path
/organization/astrazeneca-ag
Production Company Detail Path
/organization/almac-pharma-services-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Mar 6, 2019
Approval ID
7MaoUM19VYn
Type
化学药品
Back to NMPA Approvals